2 edition of Lipid A in cancer therapy found in the catalog.
Lipid A in cancer therapy
Includes bibliographical references and index.
|Statement||edited by Jean-François Jeannin.|
|Series||Advances in experimental medicine and biology -- 667, Advances in experimental medicine and biology -- v. 667.|
|Contributions||Jeannin, Jean-François, 1948-|
|LC Classifications||RC271.I45 L57 2009|
|The Physical Object|
|LC Control Number||2009035583|
Title:SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy VOLUME: 18 ISSUE: 6 Author(s):Xiang Cheng, Jianying Li and Deliang Guo* Affiliation:Department of Radiation Oncology, The Ohio State University James Comprehensive Cancer Center and College of Medicine, Columbus, OH , Department of Radiation Cited by: 7. Ding, X. Xu, Y. Zhao et al., “ Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy Cited by: 7.
Nanostructures for Cancer Therapy discusses the available preclinical and clinical nanoparticle technology platforms and their impact on cancer therapy, including current trends and developments in the use of nanostructured materials in chemotherapy and chemotherapeutics.. In particular, coverage is given to the applications of gold nanoparticles and quantum dots in . Bioactive lipid molecules promote apoptosis via the intrinsic pathway by modulating mitochondrial membrane permeability and activating different enzymes including caspases. In this review, we discuss recent data in the fields of lipid metabolism, lipid-mediated apoptosis, and cancer by:
Radiation therapy (also called radiotherapy, X-ray therapy, or irradiation) is the use of ionizing radiation to kill cancer cells and shrink tumors. Radiation therapy can be administered externally via external beam radiotherapy (EBRT) or internally via effects of radiation therapy are localised and confined to the region being lty: oncology. The co-delivery of DNA and antitumor drugs has the potential to treat cancer. In this study, we aimed to develop surface-modified, co-encapsulated solid lipid nanoparticles (SLN) containing enhanced green fluorescence protein plasmid (pEGFP) and doxorubicin (DOX) in order to create a multifunctional delivery system that targets lung cancer cells, in an effort to improve the Cited by:
teaching of medical information skills
MCQs for the MRCPsych part 1
America faces the future
Review of the U.S. Armys Health Risk Assessment for Oral Exposure to Six Chemical-Warfare Agents (Compass Series (Washington, D.C.).)
Important changes to the Pennsylvania securities act.
Distribution undertakings and the Broadcasting Act
Education in Rwanda
The Corset : A cultural history
On denoting: 1905 - 2005
Video: life processes channel 4.
Big Bill Haywood and the radical union movement.
Delbridges guide on grab hold, or, Cornish style of wrestling
Nancy and Nick in Scrub-Up-Land
In contrast, lipid A has been tested in overindividuals in various vaccines trials, including therapeutic cancer vaccines. Clearly most of the work needed to develop lipid A as effective anti-cancer agents and/or as vaccine adjuvant lies ahead in the near future. This book is a timely contribution and provides a much needed up-to-date.
This book introduces the fundamental principles of lipid nanocarriers Lipid A in cancer therapy book relevant to cancer therapy.
The first in this field, it fills a need for an accurate, coherent and authoritative introduction to lipid nanocarriers focusing on cancer therapy, both because of the growing popularity of these modern drug delivery systems and also because of the emergent need for dealing with cancer Format: Paperback.
The term ‘lipids’ refers to a class of biological molecules primarily composed of hydrocarbons such as fatty acids, glycerolipids, sphingolipids and sterol lipids. Lipids take part in a variety of physiological functions and have specific roles depending on their chemical structure and localisation within or outside cells.
For example, glycerolipids (e.g. triglycerides) are often used Author: Jin Yan Lim, Hiu Yee Kwan. Lipid-Based Nanocarriers for Drug Delivery and Diagnosis explores the present state of widely used lipid-based nanoparticulate delivery systems, such as solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), nanoliposomes, micelles, nanoemulsions, nanosuspensions and lipid nanotubes.
The various types of lipids that can be. In contrast, lipid A has been tested in overindividuals in various vaccines trials, including therapeutic cancer vaccines.
Clearly most of the work needed to develop lipid A as effective anti-cancer agents and/or as vaccine adjuvant lies ahead in the near future. This book is a timely contribution and provides a much needed up-to-date Brand: Springer-Verlag New York.
The work needed to develop lipid A as an effective anti-cancer agent lies ahead in the near future. This volume is a timely contribution and provides a much needed up. Lipid-based nanocarriers might be subdivided in vesicular carriers (liposomes) and particulate carriers (solid lipid nanoparticles, and nanostructured lipid carriers).
By lipid based vesicles are understood the spherical bilayer carriers spontaneously originated when phospholipids come into contact with an aqueous medium (Pradhan et al., Cited by: 1.
Peutz-Jeghers cancer syndrome (PJS), as well as sporadic human lung cancer, including some. types of non-small cell lung cancer (NSCLC) . AMPK has thus become a multifaceted target in cancer. Interestingly, orlistat inhibits the AMPK/ mTOR pathway in the endometrial cancer cell lines ECC-1 and KLE, and decreases the expression.
Get this from a library. Lipid A in Cancer Therapy. [Jean-François Jeannin] -- Cancer remains a major challenge for modern society.
Not only does cancer rank among the first three causes of mortality in most population groups but also the therapeutic options available for most. How to Repair Mitochondria with Lipid Replacement. Another thing is reducing the adverse effects of cancer in cancer therapy.
So there are two aspects of this. If some person has cancer, often they have what’s known as cancer associated fatigue, in the absence of any therapy. And of course the NT Factor will help patients with that.
There is a dual relationship wherein the tumor can change its microenvironment and the microenvironment can affect how a tumor grows and spreads. Tumor Microenvironment in Cancer Progression and Cancer Therapy aims to shed light on the mechanisms, factors, and mediators that are involved in the cancer cell environment.
Solid lipid nanoparticles in cancer therapy Article (PDF Available) in International Journal of Drug Delivery 2(3) October with 1, Reads How we measure 'reads'. Lipogenic enzymes such as, FAS, ACC, and ACL involved in FA biosynthesis, glycerolphosphate dehydrogenase involved in lipid biosynthesiss, and SREBP1, the master regulator oflipogenicgene expression, are found to be overexpressed in a number of cancer or cancer cells, such as prostate cancer, ovarian cancer, breast cancer, lung cancer, colon Cited by: 3.
Lipid Replacement Therapy® (LRT®) is the natural replacement of damaged lipids with precise supplements protected from oxidative damage. These are not the usual fats found in fish, butter, olive and other oils but are a unique combination of glycophospholipids clinically proven to repair the lipid portion of cell membranes and mitochondria.
Lipid-lowering therapy is best delivered by an interprofessional team consisting of physicians (both primary care and cardiologist), pharmacist, and cardiovascular specialty trained nursing staff, to guide and monitor the therapeutic course and Author: Minar Chhetry, Ishwarlal Jialal.
Lipid metabolism has therefore become implicated in a variety of oncogenic processes, including metastatic colonization, drug resistance, and cell differentiation [10, 12–16].
However, whether we can safely and effectively modulate the underlying mechanisms for cancer therapy is Cited by: Lipid Nanocarriers in Cancer Diagnosis and Therapy 1st Edition Read & Download - By Eliana Souto Lipid Nanocarriers in Cancer Diagnosis and Therapy This book introduces the fundamental principles of lipid nanocarriers science relevant to cancer - Read Online Books at.
However, other lipids are also deregulated in cancer and interfering with the synthesis or binding of these lipids are promising approaches for cancer therapy.
This Special Issue will summarize current knowledge of therapeutics that target lipids as a new treatment option for cancer therapy. Biography. Lígia Gomes-da-Silva has a degree in Pharmaceutical Sciences conferred by the Faculty of Pharmacy of University of Coimbra, in Sinceshe has been a Ph.D.
student at the Center for Neuroscience and Cell Biology (CNC) of the University of Coimbra, where she has been developing lipid-based nanoparticles for the targeted systemic delivery of nucleic. Lipid uptake may acquire further importance during conditions of metabolic stress, when the ability to meet oncogene-driven demands for biosynthesis is compromised.
Mitochondrial metabolism has also emerged as a key target for cancer therapy, in part, due to the revelation that the antidiabetic drug metformin is an anticancer by:.
Here we molecularly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and organoids and show that it depends on. Revici’s cancer therapy was a nontoxic chemotherapy that used lipids, lipid-based substances, and essential elements to correct an underlying imbalance in the patient’s chemistry.
His method was a blend of clinical observations, laboratory analyses, and chemotherapy.“Every person with an active cancer will either be too anabolic or too catabolic.” Kelley Eidem, author of the book The Doctor Who Cures Cancer, the Story of Dr Revici. Metabolic therapy. Metabolic therapy pertains to the physical and chemical processes that are involved in the maintenance of life.